Ep. 76: Neurological side effects and drug interactions of new antiviral drugs against SARS-CoV-2

Ep. 76: Neurological side effects and drug interactions of new antiviral drugs against SARS-CoV-2

Moderator: Johann Sellner (Mistelbach, Austria) Guest: Tamuna Akhvlediani (Tbilisi, Georgia) In this podcast episode, Prof. Johann Sellner interviews Prof. Tamuna Akhvlediani about the neurological aspects of new antiviral drugs for SARS-CoV-2. They discuss drugs like monoclonal antibodies, paxlovid, and remdesivir, emphasizing their mechanisms and potential applications beyond COVID-19. Prof. Akhvlediani details neurological side effects observed in trials and significant drug interactions, especially in chronic neurological patients. The episode closes with insights into managing these interactions in clinical practice.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(216)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
romkapsel
jss
liberal-halvtime
tomprat-med-gunnar-tjomlid
rekommandert
sinnsyn
forskningno
villmarksliv
rss-paradigmepodden
tidlose-historier
dekodet-2
fjellsportpodden
nordnorsk-historie
rss-rekommandert
rss-nysgjerrige-norge
grunnstoffene
nevropodden
rss-skogkurspodden